Supplementary Table 2.docx (34.35 kB)
Download file

Supplementary Table 2: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

Download (34.35 kB)
dataset
posted on 18.11.2021, 09:13 by Shin-ichi Konno, Takuya Nikaido, John D Markman, Makoto Ohta, Toshiya Machida, Naoki Isogawa, Hiroki Yoshimatsu, Lars Viktrup, Mark T Brown, Christine R West, Kenneth M Verburg

Supplementary Table 2. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized, Celecoxib-Controlled, Japanese, Phase 3, Safety Study

Summary of all-causality TEAEs through week 80 (treatment + follow-up period)


Funding

Eli Lilly & Company, Pfizer

History